Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.
The Scientist
Most Recent
A panel of advisors says that the agency should loosen restrictions on the sale of a diabetes drug with a spotty clinical safety record.
US watchdog suspends plans to discipline researchers who failed to disclose the full risks of an experimental trial conducted with premature infants.
Long-term stroke patients involved in a small-scale clinical trial of a neural stem-cell therapy show signs of recovery.
Italian lawmakers have demanded formal approval for a controversial stem-cell therapy, but allowed some patients to continue treatment under stricter rules.
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
Clinical researchers need programming support to streamline their work, minimize error in the data, and find new trends that can point to better treatments.
NIH Director Francis Collins and colleagues announce plans to create a health-care research network to connect patients, doctors, and clinical researchers.
A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
Advances in genomics and cancer biology will alter the design of human cancer studies.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
